We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Seanad
‹ An tOrd Gnó - Order of Business

High-tech cancer drugs and west hospital plans

Summary

Senator Ardagh called for a debate on funding for high-tech cancer and rare-disease drugs, and Senator Kyne then highlighted progress on a new accident and emergency, maternity and paediatric facility in the west.

I welcome the visitors from the university to the Public Gallery. I also join with my colleagues in thanking Martin Groves, Bridget Doody and all the team in the Seanad Office. People always describe the Seanad and the rest of the Oireachtas as being like a swan going along gracefully while underneath there is much going on that we do not see. I thank all the staff of the Oireachtas, including our ushers, caters and cleaners, who make this a beautiful place and a wonderful environment for us to work in. I thank everyone.

I call for a debate on the funding of high-tech drugs for cancer and rare diseases. We have procedures, systems and offices in place in this regard, such as the National Centre for Pharmacoeconomics, NCPE, and the corporate pharmaceutical unit, CPU, in the HSE. Ultimately, however, these offices and the systems in place to assess high-tech drugs are archaic and need to be reviewed in light of the technological and scientific advances that have been made. In a quote I love, Dr. Mike Ryan said during the Covid-19 pandemic that we need to be fast and have no regrets and that if we need to be right before we move, then we will never win. Many stakeholders in this context, when they are talking to us, tell us the NCPE is taking months to look at new applications for drugs. By the time the centre gets around to even looking at a drug, another has been developed. Cancer and rare disease patients, ultimately, are missing out on life-saving opportunities. After a potential new drug goes through the process with the NCPE, it then goes to the CPU of the HSE for a price to be agreed. This unit, though, is also underfunded. This is similar to the situation with many of our offices around the country which deal with applications from citizens and drug companies. It is important that we have a root-and-branch reform of how we refund and reimburse high-tech orphan drugs.

I will quickly refer to a request from a rare disease organisation. We are far behind when it comes to genetic screening in Ireland. This organisation is calling for six genomic resource associate staffing roles to be put in place as part of the Children's Hospital Ireland, CHI, group. It is important we do this. Once we spot a genetic condition, such as the BRCA gene, for instance, there are treatments and people will also be able to get assessed, monitored and live longer as a result. The request in this regard then is to allow people to live longer and healthier lives.

Comment on this

I join with other Senators in thanking Martin Groves, Bridget Doody and everyone else in the Seanad Office and all those in the Houses of the Oireachtas for their work and diligence over the last months. I wish them well over the summer break.

I acknowledge the plans by the Saolta University Health Care Group in the west to submit the preliminary business case for a new accident and emergency department and paediatric and maternity building to the Department of Health in the coming weeks. This is another step forward in a long process of delivering vital infrastructure. We saw the strategic assessment report, SAR, approved in January 2023 and planning permission granted for the demolition of the old accident and emergency department granted by Galway City Council. This is now another step in this process. We hope the Department of Health will turn this application around and allow for further steps to be undertaken in the delivery of this vital project for Galway and the region on the grounds of University Hospital Galway.

I also express concern regarding the ongoing delays in the planning process for a new ambulance base in Recess in Connemara. The team there lobbying for a new ambulance base has been carrying out that work diligently. Unfortunately, there have been more delays in the delivery of this project and the lodging of a planning application.

I certainly hope and wish that the all-Ireland rail review will be finalised and published by the Minister for Transport and the Northern Ireland executive, which I believe will recommend the reopening of the line between Athenry, Tuam and Claremorris. This is a vital piece of infrastructure for the west. It has been talked about for a long time. There have been ongoing delays. It is time to get the plan published and work started on this project.

Comment on this